openPR Logo
Press release

Global Graves’ Disease Market is anticipated to see a significant development in near future | Market Opportunities and Forecast, 2018-2023 | Major Companies: Allergan plc, Apitope Technology Ltd., Abbott Laboratories Inc., Pfizer Inc., and Merck & Co.

03-18-2019 07:19 AM CET | Health & Medicine

Press release from: Orion Market Research

Orion Market Research

Orion Market Research

According to OMR analysis, the Global Graves’ Disease Market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The global graves’ disease market has been growing significantly due to various factors consist of the increasing prevalence of thyroid disorder which is the reason for the higher pool of patient suffering from Graves’ disease. Technological advancement in the field of Graves’ disease market has led to the innovations and introduction of various treatments such as radioactive iodine, and thionamides which helps for the emerging growth of the segment. Availability of generic drugs and favorable reimbursement policies also drive the growth of the market.

A full report of the Global Graves’ Disease Market is available at https://www.omrglobal.com/industry-reports/graves-disease-market/

Furthermore, the Graves’ disease market is segmented on the basis of diagnosis, and by treatment. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. By diagnosis
• Ultrasound
• Imaging tests
• Radioactive iodine uptake
• Blood sample
2. By treatment
• Antithyroid medication
• Radioactive iodine therapy
• Surgery

Region Covered

• North America (US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profile

• Abbvie Inc.
• Abbott Laboratories Inc.
• Allergan Plc
• Apitope Technology Ltd.
• Astrazeneca Plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• EpiVax, Inc.
• GlaxoSmithKline Plc,
• Johnson & Johnson Services, Inc.
• Macleods Pharmaceuticals Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Novartis International AG
• Omeros Corp.
• Pfizer Inc.
• RLC Labs, Inc.
• Rodos Biotarget GmbH
• Sanofi Genzyme
• Takeda Pharmaceutical Company Ltd.

For related reports please visit https://www.omrglobal.com/reports-category/healthcare/

For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Contact us

Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Graves’ Disease Market is anticipated to see a significant development in near future | Market Opportunities and Forecast, 2018-2023 | Major Companies: Allergan plc, Apitope Technology Ltd., Abbott Laboratories Inc., Pfizer Inc., and Merck & Co. here

News-ID: 1658440 • Views:

More Releases from Orion Market Research

North American Cardiovascular Devices Market to Witness Growth Acceleration by 2031
North American Cardiovascular Devices Market to Witness Growth Acceleration by 2 …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance, • In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast …
The global surgical retractors market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The increasing research and development activities for the development of new and advanced medical devices by the pharmaceutical and biotechnology companies. Increasing demand for the new surgical devices by the end-users are key factors that are contributing to the growth of the surgical retractors market. For instance, • In June 2022, U.S.
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global medical packaging market is anticipated to grow with a significant CAGR of 6.1% during the forecast period. The growth of the medical packaging market is attributed to the rapidly changing healthcare industry. The medical packaging market is continuously experiencing various changes owing to the outbreak of new diseases, increasing regulatory norms, and growth in advanced healthcare systems. Furthermore, increasing development in diagnostics, pathological and other allied medical equipment

All 5 Releases


More Releases for Graves’

Japan Graves' disease Market Size & Growth Analysis Report, 2019-2025
Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in
Global Graves Disease Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Graves Disease Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Graves Disease Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/515950/graves-disease Market
US Graves' disease Market Growth, Share, Trends & Forecast to 2025
US Graves' disease market is growing at a CAGR of around 4.0% during the forecast period. The US Grave's disease market is showing significant growth due to funding for autoimmune disease researches, and the increasing prevalence of hyperthyroidism in the region. In addition, significant rise in the prevalence of autoimmune disease is also expected to propel the growth of the US Graves' disease market. According to the American Autoimmune Related
Graves Diseases Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape. Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism) . Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking and pregnancy. Treatment
Global Clinical Trials Review for Graves Diseases, H2, 2017
"The Report Graves Diseases Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Graves Diseases Global Clinical Trials Review, H2, 2017 Summary GlobalDatas clinical trial report, Graves Diseases Global Clinical Trials Review, H2, 2017" provides an overview of Graves Diseases clinical trials scenario. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1335078 This report provides top line data relating to
Graves disease Market: Positive long-term growth outlook 2017 - 2025
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism. Graves’ disease is the most predominant cause of hyperthyroidism in the